Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.
Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019
From Critical Care Explorations
The authors sought to determinewhether placental cell therapy PLacental eXpanded (PLX)-PAD (Pluristem Therapeutics, Haifa, Israel) was beneficial to treating critically ill patients suffering from acute respiratory distress syndrome due to coronavirus disease 2019.
Barkama R, Mayo A, Paz A, et al.
Estimated Time: 24:18